• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Immutep Limited

    Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer
    From Immutep Limited
    Via GlobeNewswire
    Tickers ASX:IMM IMMP
    Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
    From Immutep Limited
    Via GlobeNewswire
    Tickers ASX:IMM IMMP
    Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
    From Immutep Limited
    Via GlobeNewswire
    Tickers ASX:IMM IMMP
    Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
    From Immutep Limited
    Via GlobeNewswire
    Tickers ASX:IMM IMMP
    Immutep’s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer
    From Immutep Limited
    Via GlobeNewswire
    Tickers ASX:IMM IMMP
    Immutep Receives Approval to Initiate INSIGHT-005 Trial Evaluating Eftilagimod Alpha and Anti-PD-L1 Therapy BAVENCIO®
    From Immutep Limited
    Via GlobeNewswire
    Tickers ASX:IMM IMMP
    Immutep Enters into Second Clinical Trial Collaboration Agreement with Merck KGaA, Darmstadt, Germany, and Pfizer for New Combination Study of its First-in-Class LAG-3 Candidate, Eftilagimod Alpha, and Avelumab to Treat Urothelial Cancer
    From Immutep Limited
    Via GlobeNewswire
    Tickers ASX:IMM IMMP
    Immutep Granted New Patents in Japan and South Korea for First-in-Class LAG-3 Candidate, Eftilagimod Alpha in Chemo-Immunotherapy Combination
    From Immutep Limited
    Via GlobeNewswire
    Tickers ASX:IMM IMMP
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.